0001104659-19-015712.txt : 20190318 0001104659-19-015712.hdr.sgml : 20190318 20190318195359 ACCESSION NUMBER: 0001104659-19-015712 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190315 FILED AS OF DATE: 20190318 DATE AS OF CHANGE: 20190318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Zhang Jack Y. CENTRAL INDEX KEY: 0001611157 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 19689858 MAIL ADDRESS: STREET 1: 11570 6TH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Luo Mary Z. CENTRAL INDEX KEY: 0001611156 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 19689859 MAIL ADDRESS: STREET 1: 11570 6TH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001297184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330702205 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 909-980-9484 MAIL ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 4 1 a4.xml 4 X0306 4 2019-03-15 0 0001297184 Amphastar Pharmaceuticals, Inc. AMPH 0001611157 Zhang Jack Y. C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730 1 1 1 0 CEO & Chief Scientific Officer 0001611156 Luo Mary Z. C/O AMPHASTAR PHARMACEUTICALS, INC. 11570 6TH STREET RANCHO CUCAMONGA CA 91730 1 1 1 0 COO Chief Scientist & Chairman Common Stock 2019-03-15 4 M 0 514783 15.84 A 2587100 D Common Stock 2019-03-15 4 F 0 461097 20.23 D 2126003 D Common Stock 2019-03-15 4 A 0 98368 0 A 2224371 D Common Stock 2019-03-15 4 F 0 17205 20.23 D 2207166 D Common Stock 2019-03-16 4 F 0 27476 20.23 D 2179690 D Common Stock 2019-03-17 4 F 0 32374 20.23 D 2147316 D Common Stock 2019-03-15 4 M 0 224737 15.84 A 1591443 I See footnote Common Stock 2019-03-15 4 F 0 200853 20.23 D 1390590 I See footnote Common Stock 2019-03-15 4 A 0 41522 0 A 1432112 I See footnote Common Stock 2019-03-15 4 F 0 7317 20.23 D 1424795 I See footnote Common Stock 2019-03-16 4 F 0 11832 20.23 D 1412963 I See footnote Common Stock 2019-03-17 4 F 0 13941 20.23 D 1399022 I See footnote Common Stock 7327679 I See footnote Common Stock 5000 I See footnote Common Stock 200000 I See footnote Employee Stock Option (right to buy) 15.84 2019-03-15 4 M 0 514783 0 D 2019-03-27 Common Stock 0 0 D Employee Stock Option (right to buy) 22.25 2019-03-15 4 A 0 262182 0 A 2027-03-15 Common Stock 262182 262182 D Employee Stock Option (right to buy) 15.84 2019-03-15 4 M 0 224737 0 D 2019-03-27 Common Stock 0 0 I See footnote Employee Stock Option (right to buy) 22.25 2019-03-15 4 A 0 110671 0 A 2027-03-15 Common Stock 110671 110671 I See footnote The reported shares were withheld to satisfy the reporting person's tax liability in connection with the option exercise. The reported shares are represented by restricted stock units, or RSUs, which vest in three equal annual installments beginning on March 15, 2020. The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs. The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife. The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons and The Bill Luobei Zhang 2004 Irrevocable Trust (the "BLZ Trust") are the sole owners. The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose. The shares are held of record by the BLZ Trust. The reporting persons disclaim beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose. Shares subject to the option are fully vested and immediately exercisable. Shares subject to the option vest in three equal annual installments beginning on March 15, 2020. /s/ Eva Wen, by power of attorney for Jack Y. Zhang 2019-03-18 /s/ Eva Wen, by power of attorney for Mary Z. Luo 2019-03-18